Literature DB >> 24631698

Is there a link between ovarian cancer and tooth agenesis?

John Bonds1, Sarah Pollan-White2, Lilin Xiang1, Gabriele Mues3, Rena D'Souza4.   

Abstract

An epidemiologic study from the year 2008 found a highly significant increase of congenital tooth agenesis in women with ovarian cancer suggesting that a common genetic etiology may predispose women to both conditions. The finding was reminiscent of a previously described family harboring an AXIN2 mutation which could be shown to segregate with both the tooth agenesis and the predisposition to colon cancer transmitted in this family. Since tooth agenesis as a marker for susceptibility to ovarian cancer would be of great relevance to both oncologists and women with inborn missing teeth, the relationship between the two disorders requires a thorough assessment. We examined DNA samples from the ovarian cancer patients who participated in the original study, to look for a possible genetic connection between their ovarian malignancies and tooth agenesis. MSX1, PAX9, AXIN2, EDA, WNT10A, BARX and BRCA1 genes were selected for sequence analysis as they may cause tooth agenesis, are expressed in the female reproductive system, and/or are involved in tumorigenesis in general or specifically in the ovary. Our study revealed evidence that one half of the dually affected patients had an independent causation of the two conditions, thus reducing the previously estimated ovarian cancer risk for women with congenital tooth agenesis quite significantly.
Copyright © 2014 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  AXIN2; BARX1/2; BRCA1; EDA; Genetics; MSX1; Ovarian cancer; PAX9; Tooth agenesis; WNT10A

Mesh:

Year:  2014        PMID: 24631698      PMCID: PMC4004684          DOI: 10.1016/j.ejmg.2014.02.013

Source DB:  PubMed          Journal:  Eur J Med Genet        ISSN: 1769-7212            Impact factor:   2.708


  26 in total

1.  Mutation of PAX9 is associated with oligodontia.

Authors:  D W Stockton; P Das; M Goldenberg; R N D'Souza; P I Patel
Journal:  Nat Genet       Date:  2000-01       Impact factor: 38.330

2.  Msx1 gene overexpression induces G1 phase cell arrest in human ovarian cancer cell line OVCAR3.

Authors:  J Park; K Park; S Kim; J H Lee
Journal:  Biochem Biophys Res Commun       Date:  2001-03       Impact factor: 3.575

3.  BARX2 induces cadherin 6 expression and is a functional suppressor of ovarian cancer progression.

Authors:  G C Sellar; L Li; K P Watt; B D Nelkin; G J Rabiasz; E A Stronach; E P Miller; D J Porteous; J F Smyth; H Gabra
Journal:  Cancer Res       Date:  2001-10-01       Impact factor: 12.701

4.  Cloning, characterization, localization, and mutational screening of the human BARX1 gene.

Authors:  D B Gould; M A Walter
Journal:  Genomics       Date:  2000-09-15       Impact factor: 5.736

5.  Isolated oligodontia associated with mutations in EDARADD, AXIN2, MSX1, and PAX9 genes.

Authors:  Birgitta Bergendal; Joakim Klar; Christina Stecksén-Blicks; Johanna Norderyd; Niklas Dahl
Journal:  Am J Med Genet A       Date:  2011-05-27       Impact factor: 2.802

6.  A human MSX1 homeodomain missense mutation causes selective tooth agenesis.

Authors:  H Vastardis; N Karimbux; S W Guthua; J G Seidman; C E Seidman
Journal:  Nat Genet       Date:  1996-08       Impact factor: 38.330

7.  Canonical Wnt suppressor, Axin2, promotes colon carcinoma oncogenic activity.

Authors:  Zhao-Qiu Wu; Thomas Brabletz; Eric Fearon; Amanda L Willis; Casey Yuexian Hu; Xiao-Yan Li; Stephen J Weiss
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-27       Impact factor: 11.205

8.  The homeobox gene BARX2 can modulate cisplatin sensitivity in human epithelial ovarian cancer.

Authors:  Grant C Sellar; Karen P Watt; Li Li; Barry D Nelkin; Genevieve J Rabiasz; David J Porteous; John F Smyth; Hani Gabra
Journal:  Int J Oncol       Date:  2002-11       Impact factor: 5.650

9.  Paired-Box genes are frequently expressed in cancer and often required for cancer cell survival.

Authors:  Aleksandra Muratovska; Chaoming Zhou; Shuji He; Paul Goodyer; Michael R Eccles
Journal:  Oncogene       Date:  2003-09-11       Impact factor: 9.867

10.  Complete sequencing shows a role for MSX1 in non-syndromic cleft lip and palate.

Authors:  P A Jezewski; A R Vieira; C Nishimura; B Ludwig; M Johnson; S E O'Brien; S Daack-Hirsch; R E Schultz; A Weber; B Nepomucena; P A Romitti; K Christensen; I M Orioli; E E Castilla; J Machida; N Natsume; J C Murray
Journal:  J Med Genet       Date:  2003-06       Impact factor: 6.318

View more
  9 in total

Review 1.  Hypodontia and ovarian cancer: A systematic review.

Authors:  Christos Iavazzo; Matthaios Papakiritsis; Ioannis D Gkegkes
Journal:  J Turk Ger Gynecol Assoc       Date:  2016-01-12

Review 2.  Diagnosis of Tooth Agenesis in Childhood and Risk for Neoplasms in Adulthood.

Authors:  Priyanshi Ritwik; Kimberly K Patterson
Journal:  Ochsner J       Date:  2018

3.  Role of WNT10A in failure of tooth development in humans and zebrafish.

Authors:  Qiuping Yuan; Min Zhao; Bhavna Tandon; Lorena Maili; Xiaoming Liu; Anqi Zhang; Evan H Baugh; Tam Tran; Renato M Silva; Jacqueline T Hecht; Eric C Swindell; Daniel S Wagner; Ariadne Letra
Journal:  Mol Genet Genomic Med       Date:  2017-09-14       Impact factor: 2.183

Review 4.  Role of the Wnt signaling molecules in the tooth.

Authors:  Masato Tamura; Eiji Nemoto
Journal:  Jpn Dent Sci Rev       Date:  2016-05-05

5.  Nonsyndromic cleft lip and palate, gastric cancer and tooth agenesis.

Authors:  E-F Cardoso; D-R-B Martelli; R-A Machado; R-D Coletta; J-D de Souza; F-T Barbosa; M-F-L de Figueiredo; L-G-V Coelho; H Martelli-Júnior
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2018-01-01

6.  Clinical significance and biological role of Wnt10a in ovarian cancer.

Authors:  Ping Li; Wenlian Liu; Qian Xu; Changxiu Wang
Journal:  Oncol Lett       Date:  2017-09-26       Impact factor: 2.967

7.  Variations in AXIN2 predict risk and prognosis of colorectal cancer.

Authors:  L Otero; E Lacunza; V Vasquez; V Arbelaez; F Cardier; F González
Journal:  BDJ Open       Date:  2019-10-16

8.  Prognostic value of PAX9 in patients with esophageal squamous cell carcinoma and its prediction value to radiation sensitivity.

Authors:  Bingxu Tan; Jianbo Wang; Qingxu Song; Nana Wang; Yibin Jia; Cong Wang; Bin Yao; Zhulong Liu; Xiaomei Zhang; Yufeng Cheng
Journal:  Mol Med Rep       Date:  2017-05-25       Impact factor: 2.952

Review 9.  Congenitally missing second permanent molars in non-syndromic patients (Review).

Authors:  Alexandru-Titus Farcașiu; Rodica Luca; Andreea Didilescu; Ioana-Andreea Stanciu; Catalina Farcasiu; Arina Vinereanu; Aneta Munteanu
Journal:  Exp Ther Med       Date:  2021-12-15       Impact factor: 2.447

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.